Alps Advisors Inc Repligen Corp Transaction History

Alps Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $1,624 - $2,205	-10 Reduced 0.7%	1,415 $239,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $228,598 - $365,099	1,425 New	1,425 $267,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $203,099 - $325,029	-1,260 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$247.59 - $304.47 $6,437 - $7,916	26 Added 2.11%	1,260 $334,000
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $93,879 - $156,269	-482 Reduced 28.09%	1,234 $357,000
Q1 2021 May 07, 2021	BUY	$180.37 - $226.26 $309,514 - $388,262	1,716 New	1,716 $334,000
Q3 2018 Oct 25, 2018	SELL	$46.8 - $58.97 $596,372 - $751,454	-12,743 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$35.26 - $47.04 $449,318 - $599,430	12,743 New	12,743 $599,000
Q2 2018 Jul 25, 2018	SELL	$35.26 - $47.04 $470,474 - $627,654	-13,343 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$30.92 - $37.27 $412,565 - $497,293	13,343 New	13,343 $483,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.